Product Information
TRIUMEQ 600-50-300 MG TABLET is a brand product labeled by ViiV Healthcare Company, priced at $130.1047 per EA under NDC 49702023113. Its NADAC has been published 602 times since Dec 17, 2014.
Strength
600; 50; 300 mg/1; mg/1; mg/1
Manufacturer
ViiV Healthcare CompanyNDC
49702023113
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ABACAVIR SULFATE; DOLUTEGRAVIR SODIUM; LAMIVUDINEApproval Type
New Drug (NDA)
FDA Application
NDA205551On Market Since
8/22/2014
Pharmacological Classes
Price Statistics
The NADAC for TRIUMEQ 600-50-300 MG TABLET has been published 602 times since Dec 17, 2014, and over the history we have for it it has risen 83.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $130.1047 per EA |
|---|---|
| All-time high | $130.1157 (Jun 10, 2026) |
| All-time low | $70.8135 (Dec 17, 2014) |
| 52-week high | $130.1157 |
| 52-week low | $126.1019 |
| Median price | $98.1887 |
| Average price | $99.9865 |
| Largest weekly change | +7.9% (Feb 8, 2017) |
| Weeks tracked | 602 |
| Tracking since | Dec 17, 2014 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the abacavir sulfate, dolutegravir sodium, lamivudine market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of TRIUMEQ 600-50-300 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for TRIUMEQ 600-50-300 MG TABLET, manufactured by ViiV Healthcare Company, is $130.1047 per EA (NDC 49702023113), effective Jun 24, 2026.
How has the price of TRIUMEQ 600-50-300 MG TABLET changed over time?
Over the history we have for it, the NADAC for TRIUMEQ 600-50-300 MG TABLET has risen 83.7%. It has been tracked across 602 weekly CMS publications since Dec 17, 2014.
What are the highest and lowest recorded NADAC prices for TRIUMEQ 600-50-300 MG TABLET?
Since Dec 17, 2014, the NADAC for TRIUMEQ 600-50-300 MG TABLET has ranged from a low of $70.8135 (Dec 17, 2014) to a high of $130.1157 (Jun 10, 2026), with a median of $98.1887 per EA.
Are there cheaper alternatives to TRIUMEQ 600-50-300 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of TRIUMEQ 600-50-300 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures TRIUMEQ 600-50-300 MG TABLET?
TRIUMEQ 600-50-300 MG TABLET (NDC 49702023113) is labeled by ViiV Healthcare Company, and CMS classifies it as a brand product.
Related Drugs
Same classification